ACT001
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ACT001, covering 2021-11-19 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature [Phase 2]